Epsilon Healthcare Limited
Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in two segments, Contract Development and Manufacturing Activities; and Telehealth Medical Practice Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmace… Read more
Epsilon Healthcare Limited (HDRPF) - Total Liabilities
Latest total liabilities as of December 2024: $7.16 Million USD
Based on the latest financial reports, Epsilon Healthcare Limited (HDRPF) has total liabilities worth $7.16 Million USD as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Epsilon Healthcare Limited - Total Liabilities Trend (2016–2024)
This chart illustrates how Epsilon Healthcare Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Epsilon Healthcare Limited Competitors by Total Liabilities
The table below lists competitors of Epsilon Healthcare Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Rexel SA
BE:E7V
|
Germany | €8.12 Billion |
|
SANDVIK (SVKB.SG)
STU:SVKB
|
Germany | €90.63 Billion |
|
Inter Industries
TA:ININ
|
Israel | ILA331.13 Million |
|
IMPERIAL TOBACCO - Dusseldorf Stock Exchang
DU:ITB
|
Germany | €23.46 Billion |
|
MUEHLBAUER HOLDING - Dusseldorf Stock Exchang
DU:MUB
|
Germany | €365.83 Million |
|
OSAKA GAS - Dusseldorf Stock Exchang
DU:OSA
|
Germany | €1.38 Trillion |
|
NEURONES (NE9.SG)
STU:NE9
|
Germany | €266.34 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Epsilon Healthcare Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.52 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Epsilon Healthcare Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Epsilon Healthcare Limited (2016–2024)
The table below shows the annual total liabilities of Epsilon Healthcare Limited from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $7.16 Million | +4.11% |
| 2023-12-31 | $6.87 Million | -38.80% |
| 2022-12-31 | $11.23 Million | +2.27% |
| 2021-12-31 | $10.98 Million | -8.06% |
| 2020-12-31 | $11.94 Million | +117.47% |
| 2019-12-31 | $5.49 Million | +17.90% |
| 2018-12-31 | $4.66 Million | +691.15% |
| 2017-12-31 | $588.83K | +403.30% |
| 2016-12-31 | $116.99K | -- |